When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
JNJ - European advisory group backs expanded label for J&J's Darzalex
Johnson & Johnson
Genmab A/S (OTCPK:GNMSF) announces that the European advisory group CHMP has adopted a positive opinion recommending approval of licensee Johnson & Johnson's (NYSE:JNJ) Darzalex (daratumumab), combined with lenalidomide and dexamethasone, for treating newly diagnosed adult patients with multiple myeloma (MM) who are ineligible for autologous stem cell transplant.
More news on: Genmab A/S, Johnson & Johnson, Healthcare stocks news,